Surveillance for hepatocellular carcinoma

References

• Di Bisceglie AM. Issues in screening and surveillance for hepatocellular carcinoma. Gastroenterology 2004; 127(5 Suppl 1): S104–7
   Google Scholar
• Hoofnagle JH. Hepatocellular carcinoma: summary and recommendations. Gastroenterology 2004; 127(5 Suppl 1): S319–23
   PubMedGoogle Scholar
• El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127(5 Suppl 1): S27–34
   PubMed Web of Science ®Google Scholar
• Arguedas MR, Chen VK, Eloubeidi MA, et al. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol 2003; 98(3): 679–90
   PubMed Web of Science ®Google Scholar
• Daniele B, Bencivenga A, Megna AS, et al. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 2004; 127(5 Suppl 1): S108–12
   PubMed Web of Science ®Google Scholar
• Gambarin-Gelwan M, Wolf DC, Shapiro R, et al. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 2000; 95(6): 1535–8
   Google Scholar
• Trevisani F, Cantarini MC, Labate AM, et al. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. Am J Gastroenterol 2004; 99(8): 1470–6 [Erratum, Am J Gastroenterol 2004;99(10): 2074]
   Google Scholar
• Sherman M. Alphafetoprotein: an obituary. J Hepatol 2001; 34(4): 603–5
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000; 32(4 Pt 1): 842–6
   PubMed Web of Science ®Google Scholar
• Marrero JA, Lok ASF. Newer markers for hepatocellular carcinoma. Gastroenterology 2004; 127(5 Suppl 1): S113–9
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver. J Hepatol 2001; 35(3): 421–30
   PubMed Web of Science ®Google Scholar
• Takayasu K, Moriyama N, Muramatsu Y, et al. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. AJR Am J Roentgenol 1990; 155(1): 49–54
   Google Scholar
• Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130(7): 417–22
   PubMed Web of Science ®Google Scholar
• Sangiovanni A, Del Ninno E, Fasani P, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126(4): 1005–14
   PubMed Web of Science ®Google Scholar
• Patel D, Terrault NA, Yao FY, et al. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol 2005; 3(1): 75–84
   Google Scholar
• Befeler AS, di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122(6): 1609–19
   PubMed Web of Science ®Google Scholar
• Chalasani N, Horlander JC Sr, Said A, et al. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 1999; 94(10): 2988–93
   Google Scholar
• Choi BI. The current status of imaging diagnosis of hepatocellular carcinoma. Liver Transpl 2004; 10(2 Suppl 1): S20–5
   Google Scholar
• Trevisani F, De Notariis S, Rapaccini G, et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 2002; 97(3): 734–44
   PubMed Web of Science ®Google Scholar
• Kang JY, Lee TP, Yap I, et al. Analysis of cost-effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers. J Gastroenterol Hepatol 1992; 7(5): 463–8
   Google Scholar
• Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995; 22(2): 432–8
   Google Scholar
• Nguyen MH, Garcia RT, Simpson PW, et al. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 2002; 36(2): 410–7
   PubMed Web of Science ®Google Scholar
• Cedrone A, Covino M, Caturelli E, et al. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: Does different viral etiology influence AFP levels in HCC? A study in 350 western patients. Hepatogastroenterol 2000; 47(36): 1654–8
   PubMedGoogle Scholar
• Tong MJ, Blatt LM, Kao VW. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenteric Hepatol 2001; 16(5): 553–9
   PubMed Web of Science ®Google Scholar
• Lamerz R, Runge, Stieber P, et al. Use of PIVKA-H (DCP) determination for differentiation between benign and malignant liver disease. Anticancer Res 1999; 19(4A): 2489–93
   Google Scholar
• Grazi GL, Mazziotti A, Legnani C, et al. The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin. Liver Transpl Surg 1995; 1(4): 249–55
   Google Scholar
• Ishii M, Gama H, Chida N, et al. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Am J Gastroenterol 2000; 95(4): 1036–40
   Google Scholar
• Khien VV, Mao HV, Chinh TT, et al. Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma. Int J Biol Markers 2001; 16(2): 105–11
   PubMed Web of Science ®Google Scholar
• Taketa K, Okada S, Win N, et al. Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar. Acta Med Okayama 2002; 56(6): 317–20
   Google Scholar
• Wang SS, Lu RH, Lee FY, et al. Utility of lentil lectin affinity of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. J Hepatol 1996; 25(2): 166–71
   Google Scholar
• Oka H, Saito A, Ito K, et al. Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of lens culinaris agglutinin-reactive alpha-fetoprotein. J Gastroenterol Hepatol 2001; 16(12): 1378–83
   PubMed Web of Science ®Google Scholar